At this rate, Globus Medical, Inc. will likely reach $2.5 billion in total revenue for the 12 months ending December 31, 2024 ...
Welcome to Globus Medical's second-quarter 2024 earnings call. [Operator instructions] I'll now turn the call over to Brian ...
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company ...
Globus Maritime Limited, an integrated dry bulk shipping company, provides marine transportation services worldwide. It owns, operates, and manages a fleet of dry bulk vessels that transport iron ...
We reviewed our experience with inpatient and outpatient single-level anterior cervical discectomy and fusion with plating (ACDF+P). Methods: All patients undergoing single-level anterior cervical ...
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
The Globus-M2 spherical tokamak that Bakharev his team are working on may be an important first step towards this goal. Tokamaks confine plasma – a hot, ionized gas – using magnetic fields ...
Globus Medical, Inc. (NYSE:GMED ... REVEL-S is an expandable, standalone ACDF spacer system delivered at a minimized height to reduce impaction and tissue retraction, while providing controlled, ...
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
[12,13,14,15,16] Anterior cervical discectomy and fusion with plating (ACDF+P) is one of the most common spinal and neurosurgical procedures performed. [17,18,19] Traditionally, ACDF+P has been ...
Welcome to Globus Medical's second-quarter 2024 earnings call. [Operator instructions] I'll now turn the call over to Brian Kearns, senior vice president of business development and investor ...
Welcome to Globus Medical's second-quarter 2024 earnings call. (Operator Instructions) I'll now turn the call over to Brian Kearns, Senior Vice President of Business Development and Investor Relations ...